Nanjing Pharmaceutical Factory Co., Ltd.

Overview

Nanjing Pharmaceutical Factory Co., Ltd. is a leading pharmaceutical company focused on the development and manufacturing of a wide range of medications. As a subsidiary of China National Pharmaceutical Group Corporation (Sinopharm), the company plays a crucial role in the healthcare sector, providing essential medicines and therapeutic solutions.

Therapeutic areas

API / Drug Master Files

Nanjing Pharmaceutical Factory Co., Ltd. holds 8 active (9 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• TEDIZOLID PHOSPHATE NON-STERILE ACTIVE PHARMACEUTICAL INGREDIENTActive2024-12-04
• CALCIPOTRIENE MONOHYDRATEActive2023-11-14
• PARICALCITOLActive2023-08-04
• CLEVIDIPINE BUTYRATE, NON-STERILE ACTIVE PHARMACEUTICAL INGREDIENTActive2022-12-22
• BARICITINIBActive2022-08-04
• REGADENOSONActive2022-01-24
• AVIBACTAM SODIUM, STERILE ACTIVE PHARMACEUTICAL INGREDIENTActive2021-07-05
• IRON SUCROSEActive2013-07-15
• SUCRALFATEInactive1988-01-13

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Nanjing Pharmaceutical Factory Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.